Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078593 | SCV000110449 | benign | not specified | 2012-12-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078593 | SCV000303555 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000607305 | SCV000399677 | likely benign | PMM2-congenital disorder of glycosylation | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Gene |
RCV000078593 | SCV000519729 | benign | not specified | 2016-03-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000078593 | SCV000540062 | likely benign | not specified | 2016-06-02 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 1.9% in ExAC, 5% Finnish, 36 homozygotes |
Genome Diagnostics Laboratory, |
RCV000607305 | SCV000743898 | likely benign | PMM2-congenital disorder of glycosylation | 2014-10-09 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV000607305 | SCV000803533 | benign | PMM2-congenital disorder of glycosylation | 2018-05-31 | criteria provided, single submitter | curation | This variant is interpreted as a Benign, for Congenital disorder of glycosylation, type IA, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BS1 => Allele frequency is greater than expected for disorder. BS2 => Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age. BS3-Supporting => BS3 downgraded in strength to supporting (PMID:21541725). |
Labcorp Genetics |
RCV000607305 | SCV001728180 | benign | PMM2-congenital disorder of glycosylation | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000078593 | SCV002050876 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002055093 | SCV002497882 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | PMM2: BS1, BS2 |
Breakthrough Genomics, |
RCV002055093 | SCV005217430 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000607305 | SCV000733553 | benign | PMM2-congenital disorder of glycosylation | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078593 | SCV001923956 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000607305 | SCV002089489 | benign | PMM2-congenital disorder of glycosylation | 2019-11-05 | no assertion criteria provided | clinical testing |